Position in BCAX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,117,793
+$1,822,063 QoQ
Shares Held
558,964
+1.2% QoQ
Ownership
0.851%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 99.97405915228887.ToString("F0")%
Shared 0.ToString("F0")%
None 0.02594084771112272.ToString("F0")%
Common Shares in BCAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. BCAX ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in BCAX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,117,793 | 558,964 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,295,730 | 552,331 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $3,675,295 | 232,761 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,410,751 | 151,857 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,637,805 | 125,695 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $3,131,227 | 179,749 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,595,264 | 101,895 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||